Search research articles
Contact Us
Filters
Showing results (191-200 of 205) with videos related to
Page
of 21
Sort By:
Clinical Genitourinary Cancer
|
June 6, 2016
Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma
G Sonpavde, G R Pond, G Di Lorenzo, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 29, 2000
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)]
R Souchon, S Krege, H J Schmoll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2025
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa
M-O Grimm, J Bedke, J Nyarangi-Dix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study
H von der Maase, S W Hansen, J T Roberts, et al.
Clinical Genitourinary Cancer
|
July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design
G R Pond, J Bellmunt, J E Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
H von der Maase, S W Hansen, J T Roberts, et al.
Der Urologe. Ausg. A
|
January 15, 2009
[Complete resection of urothelial cancer metastases with curative intent]
J Lehmann, H Suttmann, P Albers, et al.
Der Urologe. Ausg. A
|
April 20, 2018
[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]
H Ahmadzadehfar, P Albers, A Bockisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group
K Fizazi, S Tjulandin, R Salvioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2026
A Simple Plan: Chemotherapy-Sparing Approaches to Early Stage and Regional Seminoma and Non-Seminoma
L Nappi, A Thor, T Tandstad, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 205) with videos related to
Sort By:
Page
of 21
Clinical Genitourinary Cancer
|
June 6, 2016
Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma
G Sonpavde, G R Pond, G Di Lorenzo, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 29, 2000
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)]
R Souchon, S Krege, H J Schmoll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2025
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa
M-O Grimm, J Bedke, J Nyarangi-Dix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study
H von der Maase, S W Hansen, J T Roberts, et al.
Clinical Genitourinary Cancer
|
July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design
G R Pond, J Bellmunt, J E Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
H von der Maase, S W Hansen, J T Roberts, et al.
Der Urologe. Ausg. A
|
January 15, 2009
[Complete resection of urothelial cancer metastases with curative intent]
J Lehmann, H Suttmann, P Albers, et al.
Der Urologe. Ausg. A
|
April 20, 2018
[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]
H Ahmadzadehfar, P Albers, A Bockisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group
K Fizazi, S Tjulandin, R Salvioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2026
A Simple Plan: Chemotherapy-Sparing Approaches to Early Stage and Regional Seminoma and Non-Seminoma
L Nappi, A Thor, T Tandstad, et al.
Page
of 21